AFYREN Resumes Production After €6M Technical Upgrade

Event summary

AFYREN completed a one-month technical shutdown in June 2026, installing new equipment and modifying existing systems at its NEOXY plant.
The €6M project involved 20,000 working hours across 4 weeks with up to 90 workers on-site daily.
Production has resumed, with AFYREN expecting accelerated output in H2 2026 after revenue doubled in H1 2026 vs. FY 2025.

The big picture

AFYREN's successful technical shutdown and production resumption reflect broader industry trends toward decarbonization and circular economy models. The €6M investment underscores the company’s commitment to scaling biobased solutions, positioning it competitively in sectors like nutrition, life sciences, and materials. With revenue doubling in H1 2026, AFYREN is poised to capitalize on growing demand for sustainable alternatives to fossil-based resources.

What we're watching

Production Scaling: How the upgraded equipment will affect AFYREN's ability to meet growing demand for biobased ingredients.
Financial Performance: Whether H2 2026 revenue growth can sustain the company’s momentum after H1 2026’s doubling of revenue.
International Expansion: The pace at which AFYREN advances its plans to enter Asian and American markets beyond its current European focus.